Hagop M. Kantarjian, MD
M.D. Anderson Cancer Center
Built from public records under this name as ClinicalTrials.gov spells it. A name can belong to more than one person, so each section says how its rows were tied to this name. No contact details are shown.
Trials
Studies that name Hagop M. Kantarjian, MD as principal investigator, study chair or study director, newest first. Live from ClinicalTrials.gov, fetched 2026-11-12 13:07 UTC. Open this list on ClinicalTrials.gov
- Ph1NCT01751425 · Ruxolitinib in Treating Participants With Chronic Myeloid Leukemia With Minimal Residual Disease While on Therapy With Tyrosine Kinase InhibitorsM.D. Anderson Cancer Center · terminated · Chronic Myelogenous Leukemia, BCR-ABL1 Positive, Chronic Myelogenous Leukemia, BCR-ABL1 Positive in Remission, Minimal Residual Disease · principal investigator
- Ph1/Ph2NCT01211457 · Study of Sapacitabine in Acute Myeloid Leukemia (AML) or Myelodysplastic Syndromes (MDS)Cyclacel Pharmaceuticals, Inc. · unknown · Acute Myeloid Leukemia, Myelodysplastic Syndromes
- Ph2NCT00590187 · Efficacy Study of Oral Sapacitabine to Treat Acute Myeloid Leukemia in Elderly PatientsCyclacel Pharmaceuticals, Inc. · completed · Acute Myeloid Leukemia
- Ph2NCT00255346 · Dasatinib as Therapy for Myeloproliferative Disorders (MPDs)M.D. Anderson Cancer Center · completed · Acute Myeloid Leukemia, Myelodysplastic Syndromes, Agnogenic Myeloid Metaplasia
- Ph2NCT00098033 · Investigation of Clofarabine in Acute LeukemiasUniversity of Texas · completed · Acute Myelogenous Leukemia, Acute Lymphocytic Leukemia, Chronic Myelogenous Leukemia
- Ph2NCT00003239 · Chemotherapy and Biological Therapy in Treating Patients With Chronic Phase Chronic Myelogenous LeukemiaM.D. Anderson Cancer Center · completed · Leukemia · study chair
- Ph2NCT00067808 · Study of Three Different Schedules of Low-Dose Decitabine in Myelodysplastic Syndrome (MDS)M.D. Anderson Cancer Center · completed · Myelodysplastic Syndrome, Chronic Myelomonocytic Leukemia
Grants
NIH projects from RePORTER, fetched 2026-11-12 13:07 UTC. A project is listed only when its grant number is on one of the trials above, or when the awardee institution matches an affiliation the registry gives for this name. Coverage is US federal funding only; UK and EU funders are not searched yet.
No NIH project could be tied to this name by a shared trial or a matching institution.
NIH grants that fund their trials
These grant numbers are on the registry records of the trials above. They fund the trial, often through a cooperative group or network, and their principal investigator is usually someone else.
- Experimental Medicine ProgramP30CA016672 · NCI · UNIVERSITY OF TX MD ANDERSON CAN CTR · PI FUNDA MERIC-BERNSTAM · fiscal years 2013 to 2026Named on NCT01751425, NCT00003239
- U01CA070172RePORTER returned no project for this number; it is shown as the registry gives it.Named on NCT00003239
Most cited trial papers
PubMed returned no clinical-trial papers for this author name in chronic myeloid leukemia.